Novartis' Genomics Institute Partners with JDRF | GenomeWeb

NEW YORK (GenomeWeb News) – Novartis' genomics research arm will collaborate with the Juvenile Diabetes Research Foundation (JDRF) in a drug discovery and development program focused on Type 1 diabetes, JDRF said on Wednesday.

The Genomics Institute of the Novartis Foundation (GNF) will collaborate with JDRF in a four-year program that will be overseen by a review committee made up of GNF and JDRF members and by a scientific advisory board and JDRF volunteers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.